Researchers showed that a severe drop in NAD+—a core energy molecule—drives Alzheimer’s pathology in both human brains and mouse models.

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

The pathology of Alzheimer’s disease was identified in 1906. We remain with neither cure nor treatments that reverse symptoms or stop disease progression. Recently approved treatments have succeeded ...

Alzheimer's disease (AD) is a type of dementia that causes problems with memory, thinking, and behavior. It affects more than 5 million Americans. The Alzheimer's Association estimates that some 16 ...

Recent groundbreaking scientific findings have unveiled a surprising link between the timing of our dreams and cognitive health. This connection, if further validated, could shift the way we ...

November is Alzheimer’s Awareness Month, a time to spotlight the growing impact of the disease across the United States and Nevada is no exception. With new advancements in prevention and treatment, ...

This article explores how chronic periodontitis may contribute to Alzheimer’s disease through systemic inflammation, oral pathogens, and neurodegenerative mechanisms. It highlights prevention, ...

People with multimorbidity, defined as two or more long‐term conditions occurring within the same patient at the same time, experienced an increased risk of dementia compared to those without, ...

For decades, Alzheimer’s research has largely focused on slowing decline, not restoring what was lost. Now a series of animal ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the University of North Carolina reveals early signs of Alzheimer’s decades ...